The Erbb2 mice with hetSrsf3 KO showed intermediate outcome in overall tumor formation, and mice without Erbb2 failed in breast tumor induction during 18 months of observation period (Figure 1D). The gene discussed is ERBB2; the disease is breast neoplasm.